| NO MALE (n = 108) | MALE (n = 93) | p value |
---|---|---|---|
Men/female, n | 78:30 | 72:21 | 0.40 |
Age, years ± SD | 74.1 ± 9.3 | 75.8 ± 8.4 | 0.19 |
Diabetes duration, years ± SD | 11.4 ± 0.8 | 11.4 ± 0.8 | 0.77 |
BMI, Kg/m2 ± SD | 26.7 ± 0.6 | 26.7 ± 0.7 | 0.63 |
Smoking (current), n (%) | 47 (43.5) | 56 (60.2) | 0.02 |
Smoking (former), n (%) | 46 (42.6) | 22 (23.7) |  < 0.01 |
Never smoked, n (%) | 16 (14.8) | 15 (16.1) | 0.80 |
Hypertension, n (%) | 80 (74.1) | 66 (71.0) | 0.62 |
Hypercholesterolemia, n (%) | 55 (50.9) | 54 (58.1) | 0.31 |
CAD, n (%) | 51 (47.2) | 41 (44.1) | 0.56 |
CVD, n (%) | 51 (47.2) | 48 (51.6) | 0.53 |
Oral antidiabetic agents, n (%) | 48 (44.4) | 41 (44.1) | 0.95 |
Insulin, n (%) | 73 (67.6) | 74 (79.6) | 0.06 |
ABI, ± SD | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.88 |
Rutherford II-4, n (%) | 60 (55.6) | 49 (52.7) | 0.68 |
Rutherford III-5, n (%) | 48 (44.4) | 44 (47.3) | 0.68 |
WIfI010, n (%) | 36 (33.3) | 25 (26.9) | 0.32 |
WIfI020, n (%) | 26 (24.1) | 25 (26.9) | 0.64 |
WIfI110, n (%) | 26 (24.1) | 23 (24.7) | 0.91 |
WIfI120, n (%) | 20 (18.5) | 20 (21.5) | 0.60 |
HbA1c, % ± SD | 8.8 ± 0.7 | 8.9 ± 0.7 | 0.10 |
FBG, mg/dL ± SD | 128.6 ± 9.8 | 127.1 ± 9.3 | 0.27 |
Total cholesterol, mg/dL ± SD | 215.3 ± 23.1 | 223.0 ± 20.7 | 0.01 |
LDL cholesterol, mg/dL ± SD | 111.9 ± 15.5 | 113.0 ± 15.4 | 0.61 |
Triglycerides, mg/dL ± SD | 171.4 ± 8.3 | 173.8 ± 8.5 | 0.04 |
eGFR, mL/min/1.73m2 ± SD | 72.5 ± 10.7 | 72.6 ± 10.4 | 0.95 |
HMGB-1, ng/mL ± SD | 4.8 ± 2.6 | 7.2 ± 2.0 |  < 0.01 |